Home
News
News archive
Diamond Information
|
home > news FDA approves ketamine-like nasal spray for depression
FDA approves ketamine-like nasal spray for depression
The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.'s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K.
|
Click Here to read the entire article...
Find this article in Google |